Quick Summary
- LRCX reached a record peak of $275.99, climbing 5.56% in a single session
- Shares have delivered a remarkable 252% gain over the trailing twelve months
- Wall Street analysts have boosted price targets to between $310 and $340
- Senior executive Neil Fernandes executed a $4.6M stock sale on May 1 via pre-arranged trading plan
- New U.S. export controls targeting China’s Hua Hong create potential revenue risks
Lam Research (LRCX) touched a fresh record high of $275.99 during trading on May 5, 2026, posting a daily advance exceeding 5.5%. This milestone caps off an extraordinary twelve-month period that has seen the semiconductor equipment manufacturer deliver total returns of 252%, elevating its market capitalization to $343 billion.
Lam Research Corporation, LRCX
Top-line performance has expanded approximately 27% over the past year. The corporation maintains a Piotroski Score of 9, indicating robust financial strength according to metrics monitored by InvestingPro.
Shares currently command a price-to-earnings multiple of 48.75. According to InvestingPro’s valuation framework, LRCX appears to be trading above its calculated Fair Value threshold.
Wall Street analysts have been actively revising their projections upward. Following the company’s fiscal third-quarter earnings that surpassed both internal and Street expectations, Stifel elevated its price objective to $325 while maintaining its Buy recommendation.
TD Cowen took an even more bullish stance, pushing its target to $340. The firm highlighted the company’s expanding market position in foundry and DRAM segments, alongside anticipated expansion in NAND wafer fabrication equipment investments.
Cantor Fitzgerald maintained its Overweight stance with a $320 price objective. The firm referenced an enhanced wafer fabrication equipment outlook extending through calendar 2026, with sector expansion projected at a minimum of 27%.
UBS reaffirmed its Buy recommendation with a $310 target price, emphasizing that LRCX is positioned at the forefront of an AI-powered expansion cycle.
Executive Stock Transaction Sparks Interest
Senior Vice President Neil Fernandes divested 18,170 shares on May 1 at a price of $255.14 per share, generating approximately $4.64 million in proceeds. The transaction occurred under a Rule 10b5-1 trading arrangement that Fernandes established on November 17, 2025.
Following this sale, Fernandes retains direct ownership of 66,129 shares. Additionally, he maintains indirect holdings of slightly more than 1,015 shares through a 401(k) retirement account.
Pre-arranged trading plans of this nature are standard practice among corporate executives and typically don’t signal specific sentiment regarding future stock performance.
Export Controls Create Potential Headwind
The path forward isn’t without challenges. The U.S. Department of Commerce introduced new export limitations on semiconductor manufacturing equipment destined for Hua Hong, China’s second-largest chip producer. Lam Research was among several American equipment suppliers impacted by these measures.
These regulatory actions initially triggered a selloff across chip equipment stocks when announced. The full revenue implications for LRCX stemming from these restrictions remain unclear at this stage.
Fiscal fourth-quarter guidance exceeded Wall Street’s projections. The organization is already achieving profitability and revenue benchmarks it had initially projected for calendar year 2028.
LRCX’s fiscal third-quarter performance exceeded both Stifel’s forecasts and broader consensus estimates, catalyzing the recent round of analyst target increases.
Shares finished the May 5 trading session at or very close to the record high of $275.99.





